Canadian Investment Regulatory Organization Trade Resumption - AAV.DB

Stock Information for Aion Therapeutic Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aion Therapeutic Inc.

Advantage Announces Board Appointment
Entropy Inc. Appointment of Chief Executive Officer
Advantage Announces Second Quarter 2024 Financial and Operating Results
Methanex and Entropy Partner to Reduce Emissions in Methanol Production
Advantage Announces Revised 2024 Guidance Including Reduced Gas Drilling Program and Updated Corporate Presentation
Entropy Inc. Announces Glacier Phase 2 Final Investment Details, First Clean Power Investment, and Corporate Update
Advantage Announces Closing of Asset Acquisition
Advantage Announces Exercise in Full of Debenture Over-Allotment Option in Connection with Bought Deal Financing

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.